Baltimore, Maryland 21287


Purpose:

The purpose of this study is to determine whether application of an incisional wound Prevena trademark (TM) dressing (applies negative pressure to wounds) in the obese (BMI ≥30) surgical patient will reduce surgical site infections (SSI) when compared to the standard of care dressing.


Study summary:

In an attempt to decrease wound infection incidence and improve healing time of open surgical wounds, vacuum assisted closure (VAC) was developed. This innovative technique provided contained controlled wound irrigation without bacterial aerosolization. A newer customizable subset of the Prevena incision Management System TM called Prevena Peel and Place TM has been released a few months ago. The new model can be cut to specific wound sizes and has a connector that can be attached to the already widely available VAC machines. The versatility and the comparability to older models of Prevena Peel and Place TM have not been tested to this date. The investigators believe that a randomized clinical trial evaluating the use of the Prevena Incision Management System TM for homecare and the use of Prevena Peel and Place TM for inpatients in special populations is warranted. Obese patients (BMI≥30) undergoing open surgery will have decreased surgical site infection rates, improved healing time, better quality of life (QOL) and lower readmission rates with use of Prevena in the post-operative management of surgical incisions.


Criteria:

Inclusion Criteria: - Patient has been informed of the nature of the study, and has provided written informed consent, approved by the appropriate Institutional Review Board (IRB) / Medical Ethics Committee (MEC) of the respective clinical site. - Patient meets the criteria for and is undergoing open surgery at Johns Hopkins Medical Institutes. - Patient with BMI≥ 30 at the time of surgery - Patient agrees to return for all required clinical follow up for the study. Exclusion Criteria: - Known allergic reaction to acrylic adhesives or silver. - Known history of intolerance to any component of Prevena Incision Management System TM. - Very fragile skin around incision site. - Bleeding disorder or refuses blood transfusion. - Malignancy or other condition limiting life expectancy to <5 years. - Pregnancy


NCT ID:

NCT02461433


Primary Contact:

Principal Investigator
Kimberley Steele, MD, PHD
Johns Hopkins University

Tammam Obeid, MBBS
Phone: 4105509509
Email: tobeid1@jhmi.edu


Backup Contact:

Email: lframe2@jhmi.edu
Leigh Peterson, MHS, PHD
Phone: 4105504472


Location Contact:

Baltimore, Maryland 21287
United States

Tammam Obeid, MBBS
Phone: 410-550-9509
Email: tobeid1@jhmi.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.